BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33410357)

  • 1. Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment.
    Kakkar S; Singh M; Mohan Karuppayil S; Raut JS; Giansanti F; Papucci L; Schiavone N; Nag TC; Gao N; Yu FX; Ramzan M; Kaur IP
    J Drug Target; 2021 Jul; 29(6):631-650. PubMed ID: 33410357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
    Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
    Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
    Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and Characterization of Pectin Films Containing Solid Lipid Nanoparticles for Buccal Delivery of Fluconazole.
    Hirun N; Mahadlek J; Limmatvapirat S; Sriamornsak P; Yonemochi E; Furuishi T; Kraisit P
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.
    Nasr M; Teiama M; Ismail A; Ebada A; Saber S
    Drug Deliv Transl Res; 2020 Dec; 10(6):1841-1852. PubMed ID: 32779112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Nanoparticles Traverse Non-Corneal Path to Reach the Posterior Eye Segment: In Vivo Evidence.
    Puglia C; Santonocito D; Romeo G; Intagliata S; Romano GL; Strettoi E; Novelli E; Ostacolo C; Campiglia P; Sommella EM; Pignatello R; Bucolo C
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).
    Yadav M; Schiavone N; Guzman-Aranguez A; Giansanti F; Papucci L; Perez de Lara MJ; Singh M; Kaur IP
    Drug Deliv Transl Res; 2020 Aug; 10(4):919-944. PubMed ID: 32270439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
    Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY
    Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Generation of Fluconazole: A Review on Existing Researches and Technologies.
    Behtash A; Nafisi S; Maibach HI
    Curr Drug Deliv; 2017; 14(1):2-15. PubMed ID: 27138299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved yeast delivery of fluconazole with a nanostructured lipid carrier system.
    Kelidari HR; Moazeni M; Babaei R; Saeedi M; Akbari J; Parkoohi PI; Nabili M; Gohar AA; Morteza-Semnani K; Nokhodchi A
    Biomed Pharmacother; 2017 May; 89():83-88. PubMed ID: 28222399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits.
    Liang Z; Zhang Z; Yang J; Lu P; Zhou T; Li J; Zhang J
    Int J Nanomedicine; 2021; 16():7847-7857. PubMed ID: 34876813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermosensitive and mucoadhesive gels containing solid lipid nanoparticles loaded with fluconazole and niosomes loaded with clindamycin for the treatment of periodontal diseases: a laboratory experiment.
    Saeidi Z; Giti R; Emami A; Rostami M; Mohammadi F
    BMC Oral Health; 2024 May; 24(1):551. PubMed ID: 38734599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
    Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
    Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
    Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
    Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.